The agreement aims to accelerate breakthroughs in autism and neuroscience through joint expertise, project teams, and knowledge-sharing

King Faisal Specialist Hospital and Research Centre (KFSHRC) has entered into a Memorandum of Understanding with Cleveland Clinic, a leading non-profit academic medical center globally, to work together on clinical, operational, educational, and research initiatives involving autism and neurosciences. This strategic move highlights KFSHRC’s dedication to broaden its international collaborations to achieve medical excellence and innovation in patient care.

The MOU was signed at KFSHRC’s Riyadh headquarters by H.E. Dr. Majid Alfayyadh, KFSHRC’s Chief Executive Officer, and Dr. Tomislav Mihaljevic, Cleveland Clinic’s Chief Executive Officer and President.

The MOU details the parties’ intention to create a long-term framework for collaboration in autism and neuroscience. This involves forming specialised project teams to jointly evaluate and prioritise potential partnership opportunities, aimed at enhancing KFSHRC’s role in providing specialised healthcare.

This partnership is part of KFSHRC’s larger strategy to forge impactful global collaborations centred on knowledge exchange and capacity building, which support advancements in research, education, and workforce development. The initiative is aligned with the Health Sector Transformation Program, one of the Vision 2030 initiatives, which aims to ensure equitable access to high-quality healthcare with a strong emphasis on preventive care.